RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.01
+3.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 409.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.43x
- Price / sales
- 381.33x
- Price / cash flow
- -18.60x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 296.28x
- EV / EBITDA
- -10.80x
- EV / EBIT
- -9.88x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026